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Abstract
Background: Accuracy of rapid diagnostic tests for dengue infection has been repeatedly estimated by comparing those
tests with reference assays. We hypothesized that those estimates might be inaccurate if the accuracy of the reference
assays is not perfect. Here, we investigated this using statistical modeling.
Methods/Principal Findings: Data from a cohort study of 549 patients suspected of dengue infection presenting at
Colombo North Teaching Hospital, Ragama, Sri Lanka, that described the application of our reference assay (a combination
of Dengue IgM antibody capture ELISA and IgG antibody capture ELISA) and of three rapid diagnostic tests (Panbio NS1
antigen, IgM antibody and IgG antibody rapid immunochromatographic cassette tests) were re-evaluated using Bayesian
latent class models (LCMs). The estimated sensitivity and specificity of the reference assay were 62.0% and 99.6%,
respectively. Prevalence of dengue infection (24.3%), and sensitivities and specificities of the Panbio NS1 (45.9% and 97.9%),
IgM (54.5% and 95.5%) and IgG (62.1% and 84.5%) estimated by Bayesian LCMs were significantly different from those
estimated by assuming that the reference assay was perfect. Sensitivity, specificity, PPV and NPV for a combination of NS1,
IgM and IgG cassette tests on admission samples were 87.0%, 82.8%, 62.0% and 95.2%, respectively.
Conclusions: Our reference assay is an imperfect gold standard. In our setting, the combination of NS1, IgM and IgG rapid
diagnostic tests could be used on admission to rule out dengue infection with a high level of accuracy (NPV 95.2%). Further
evaluation of rapid diagnostic tests for dengue infection should include the use of appropriate statistical models.
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Introduction
Dengue infection is a leading cause of illness and death in the
tropics and subtropics. The causative organisms are mosquito-
transmitted Dengue viruses, and patients may present with a range
of clinical syndromes including viral syndrome, acute undifferen-
tiated febrile illness, dengue fever, dengue hemorrhagic fever and
dengue shock syndrome. On presentation, dengue infection often
presents with symptoms and signs similar to other acute tropical
infectious diseases, and a range of rapid diagnostic tests has been
recommended for early diagnosis and patient management [1,2].
There are two main methods for diagnosing dengue infection,
namely virus and antibody detection. Virus detection includes viral
isolation, polymerase chain reaction (PCR) and detection of
nonstructural protein-1 (NS1) antigen. Antibody detection in-
cludes haemagglutination inhibition (HAI) tests and enzyme linked
immunosorbent assay (ELISA) for detection of dengue IgM and
IgG antibodies, usually using paired serum collections and
assessing for a quantitative rise in antibody levels. Virus isolation
and HAI are considered the gold standard techniques for virus and
antibody detections, respectively, but are rarely used since they are
time-consuming and laborious [3]. We have repeatedly used the
Armed Forces Institute of Medical Sciences (AFRIMS) diagnostic
serology methodologies on paired sera as a reference assay to
determine the accuracy of alternative diagnostic tests [1,4–7]. We
hypothesized that the accuracy of this reference assay is imperfect,
and that the accuracy of the alternative diagnostic tests estimated
by comparing them with the reference assay might have been
underestimated.
Bayesian latent class models (LCMs) have been increasingly
used to evaluate the true accuracy of diagnostic tests in prospective
cohort studies, as they do not require the assumption that any test
is perfect [8–11]. The objective of this study was to use Bayesian
LCMs to analyze existing data from a cohort of patients presenting
to hospital with suspected dengue infection. We estimated the
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accuracy of three rapid diagnostic tests (Panbio NS1, IgM and IgG
cassette tests), our reference assay for dengue infection, and the
combination of all three rapid tests when used at clinical
presentation.
Materials and Methods
Study patients and diagnostic tests
The data analyzed in this study was generated during a
prospective cohort study of patients suspected of dengue infection.
In brief, patients were recruited between June 2006 and June 2007
at Colombo North Teaching Hospital, Ragama, Sri Lanka.
Inclusion criteria were the presence of fever ($38uC) in patients
aged 16 years or more who were suspected to have dengue
infection. Blood samples were collected on admission and, where
possible, at discharge and at follow-up 2–4 weeks later for
convalescent-phase specimens. All specimens were stored at
285uC while at the clinical site and transported on dry ice to
Bangkok, Thailand, for the test assessments. Reported elsewhere, a
case-control study using samples from a subset of 259 of the
patients recruited into the cohort was performed to evaluate six
commercial point-of-care tests for acute dengue infections by
comparing those tests with the reference assay [6].
For the purpose of the current study, all patients enrolled into
the cohort were evaluated. In the cohort, every patient was tested
with three rapid diagnostic tests including the Panbio first
generation NS1 antigen strip, the Panbio Duo cassette IgM/IgG
(Inverness, Australia), and our reference assay. NS1 antigen strip
tests were performed on admission samples only. Dengue
reference assays were performed at AFRIMS, Bangkok, Thailand
as previously described (Figure 1) [7]. In short, AFRIMS tested
paired admission and convalescent specimens using dengue (DEN)
IgM antibody capture (MAC) ELISAs, IgG antibody capture
(GAC) ELISA, and equivalent Japanese encephalitis virus (JEV)
MAC and GAC ELISAs [12–16]. An acute primary dengue
infection was diagnosed if (1) on the admission sample, the DEN
MAC ELISA result was $40 units (U), the ratio of DEN MAC
ELISA to JEV MAC ELISA results was $1 and the ratio of DEN
MAC ELISA to DEN GAC ELISA results was $1.8:1, or (2) the
DEN MAC ELISA result on the admission sample was ,15 U
and in the convalescent-phase specimen $30 U. An acute
secondary dengue infection was diagnosed if (1) on the admission
sample, the DEN MAC ELISA result was $40 U, the ratio of
DEN MAC ELISA to JEV MAC ELISA results was $1 and the
ratio of DEN MAC ELISA to DEN GAC ELISA results was
,1.8:1, or (2) the DEN MAC ELISA on the admission sample was
,40 U, the ratio of DEN GAC ELISA results on the convales-
cent-phase specimen compared to the admission specimen was $2
(2-fold rise) and the DEN GAC ELISA result on the convalescent-
phase specimen was $100. An acute JEV infection was defined if
the DEN MAC ELISA result on the admission sample was$40 U
and the ratio of DEN MAC ELISA to JEV MAC ELISA results
was ,1.
Ethics statement
Ethical approval for the cohort study was obtained from the
Faculty of Medicine, University of Kelaniya in Sri Lanka, the
Liverpool School of Tropical Medicine in the UK and the Walter
Reed Army Institute of Research in the USA. Written informed
consent was obtained from each subject enrolled into the study.
Statistical analysis
AFRIMS serological assay as Gold Standard
Model. Three rapid diagnostic test results (NS1 antigen strip,
IgM cassette test and IgG cassette test) were analyzed using the
reference assay results as the gold standard. Prevalence, sensitiv-
ities, specificities, positive and negative predictive values for the
three rapid diagnostic tests were calculated with exact 95%
confidence intervals using the Stata 11.0 statistical software
package (Stata Corp., College Station, Texas).
Bayesian Latent Class Models. Use of LCMs and Bayesian
LCMs to determine the accuracy of diagnostic tests when the
accuracy of the gold standard is imperfect or unknown has been
described in detail elsewhere [17,18]. In brief, Bayesian LCMs do
not assume that any test is perfect, but consider that each test
could be imperfect in diagnosing the true disease status. The true
disease status of the patient population is then defined on the basis
of overall prevalence (the probability that a patient with suspected
dengue is truly infected with dengue virus). LCMs estimate
prevalence and accuracy of each test based on the observed
frequency of the possible combinations of test results.
To estimate the accuracy of a diagnostic test by use of LCMs,
the best-fitting model, as determined by the presence or absence of
correlation between diagnostic tests in the model, should be used
[19]. Possible correlations we evaluated were based on existing
knowledge and external evidence. Therefore, correlations amongst
serological tests (IgM, IgG and reference tests) were considered.
The deviance information criterion (DIC) and Akaike information
criterion (AIC) were used to evaluate goodness of model fit and to
compare models. A difference in DIC or AIC of more than 10
indicated definite support to the model with the lower value, while
a difference of between 5 and 10 was considered substantial, and
less than 5 inconclusive. The best-fitted model was used to
determine the accuracies of the three diagnostic tests and of their
combinations on paired specimens. Then, the accuracies of the
diagnostic tests on clinical presentation were determined by using
test results for the admission samples only. All models assumed
that no prior information (non-informative priors) about the
unknown parameters (prevalence, sensitivities and specificities) was
available. All parameters and associated 95% credible intervals
(CrI) were estimated using WinBUGS 1.4 [20]. Text S1 and Text
S2 provide full data sets and all of the models used, respectively.
Post-hoc model evaluation. The prediction accuracy of the
final Bayesian LCM was evaluated by comparing the prevalence
estimated and the final diagnoses made in the cohort study. Final
diagnoses were based on microbiology results and physicians’
judgment if all microbiology results were negative. Final diagnoses
of dengue infection were categorized into four groups, following
the dengue classification and case definitions of symptomatic
dengue virus infections as described by WHO: (i) undifferentiated
fever or viral syndrome, (ii) dengue fever, (iii) dengue hemorrhagic
fever and (iv) dengue shock syndrome [21].
Sensitivity analysis. Sensitivity analyses were performed in
which patients without convalescent samples were excluded and
also in which different prior information were used [22,23].
Results
A total of 617 patients with fever and suspected dengue infection
were included in the cohort study. Of these, 68 (11%) patients
were excluded from further analysis because the result of at least
one diagnostic test on the admission sample was not available. Of
549 patients included in the analysis, the median age was 35 years
old (interquartile range [IQR], 25–50 years old), and 371 (68%)
were male. Convalescent samples were available in 290 (52.8%)
patients. Median time between onset of symptoms and collection
of admission samples was 5 days (IQR, 3–8 days), and median
Diagnostic Tests for Dengue Infection
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time between onset of symptoms and collection of convalescent
samples was 24 days (IQR, 19–30 days).
The final diagnoses of the 549 patients were dengue infection
(135, 24.6%), chikungunya (102, 18.6%), leptospirosis (33, 6.0%),
confirmed infections with no organism identified (38, 6.9%),
various bacteraemias (23, 4.2%), confirmed non-infectious diseases
causing fever (18, 3.2%), Q fever (17, 3.1%), rickettsial infections
(14, 2.6%), tuberculosis (5, 0.9%), urinary tract infection (5, 0.9%),
mumps (2, 0.4%), varicella (1, 0.2%), viral hepatitis (1, 0.2%),
malaria (1, 0.2%), hantavirus infection (1, 0.2%) and undiagnosed
febrile illnesses (184, 33.5%). The total number of diagnoses
exceeds 549 as 31 cases had more than one diagnosis. Ten (1.8%)
patients died in hospital due to leptospirosis (4, 40%), cerebrovas-
cular accidents (3, 30%), liver failure (2, 20%) and leukaemia (1,
10%). Of 135 patients diagnosed with dengue infection, 131 had
dengue fever, 4 had dengue hemorrhagic fever, and none had
dengue shock syndrome.
Of 549 patients, 84 (15.3%) had positive results on the reference
assay for dengue infection (26 primary infections and 58 secondary
infections). None were positive for acute JEV infection. The NS1
antigen strip test, IgM cassette test and IgG cassette test were
positive in 69, 91 and 147 patients, respectively. Only 13 patients
(2.4%) were positive for the reference assay and all three rapid
diagnostic tests.
Reference assay as a perfect gold standard
We first assumed that the reference assay was a perfect gold
standard (100% sensitivity and 100% specificity), and used this
assumption to calculate sensitivities, specificities, PPVs and NPVs
of the three rapid diagnostic tests and their combinations (Table 1).
The estimated prevalence of dengue infection in the study
population was 15.3%. The NS1 antigen test, IgM cassette test
and IgG cassette test all had low sensitivity (54.8%, 50.0% and
61.9%, respectively) with variable specificity (95.1%, 89.5%, and
79.6%, respectively).
Bayesian LCM
Bayesian LCMs were then applied to obtain an unbiased
estimate of the accuracy of each diagnostic test. The models
included all four diagnostic tests, including NS1 antigen test, IgM
cassette test, IgG cassette test and our reference assay. First, we
defined the best fitting Bayesian LCM by determining the
presence of correlations between all three serological tests (IgM
cassette test, IgG cassette test and our reference assay). Of the five
plausible models (Table 2), the difference in DIC and AIC
between the best fitting model (model 2) and the other four models
were inconclusive (differences were less than 5). Table S1 shows
the prevalence and accuracy of diagnostic tests estimated by all
five models. In short, there was no substantial difference between
all five models. Model 2, which had the lowest DIC and AIC, and
included the correlation between IgM and IgG cassette tests, was
selected as the best-fitted model.
Using this model, the prevalence of dengue infection in the
study population was estimated to be 24.3% (95% CrI 19.1%–
30.0%,). The Bayesian LCM indicated that the reference assay
had very high specificity (99.6, 95% CrI 97.9%–100%), but low
sensitivity (62.0%, 95% CrI 49.5%–75.9%). Sensitivities and
specificities of the Panbio NS1 (45.9% and 97.9%), IgM (54.5%
and 95.5%) and IgG (62.1% and 84.5%) estimated by Bayesian
LCM were significantly different from those estimated by
assuming that the reference assay was perfect. Sensitivity and
specificity for a combination of NS1 and IgM rapid tests, where a
sample was defined as positive if either test was positive, were
78.9% and 93.7%, respectively. Sensitivity and specificity for a
Figure 1. Flowchart showing the AFRIMS diagnostic algorithm for dengue infection.
doi:10.1371/journal.pone.0050765.g001
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combination of NS1, IgM and IgG rapid tests, where a sample was
defined as positive if any test was positive, were 91.7% and 79.8%,
respectively (Table 1).
To determine the accuracy of the rapid serological tests on
clinical presentation, only test results of IgM and IgG cassette test
on admission samples were considered using the best-fitted
Bayesian LCM. The sensitivity of IgM cassette test and IgG
cassette test on clinical presentation was 39.7% and 42.6%,
respectively. Sensitivity and specificity of a combination of NS1
and IgM were 72.8% and 94.7%, respectively, with positive
predictive value (PPV) and negative predictive value (NPV) of
81.5% and 91.6%, respectively. Sensitivity and specificity of a
combination of NS1, IgM and IgG rapid tests were 87.0% and
82.8%, respectively, with PPV and NPV of 62.0% and 95.2%
respectively.
Post-hoc model validation
According to the final diagnoses, 24.6% of the patients were
classified as dengue infection (dengue fever or dengue hemorrhagic
fever). This indicated that the estimated prevalence of dengue
infection in the study population using Bayesian LCMs (24.3%)
was credible.
Table 1. Prevalence and sensitivities, specificities, and positive and negative predictive values (PPV’s and NPV’s) of diagnostic tests
using the reference assay as gold standard and for final Bayesian latent class models.
Parameters Reference assay as gold standarda Final Bayesian latent class modelb
Final Bayesian latent class model (using
admission sample only)b
Prevalence 15.3 (12.4–18.6) 24.3 (19.1–30.0) NA
Reference assay
Sensitivity 100 62.0 (49.5–75.9) NA
Specificity 100 99.6 (97.9–100) NA
PPV 100 97.8 (89.7–99.9) NA
NPV 100 89.1 (83.1–94.1) NA
Panbio NS1 antigen test
Sensitivity 54.8 (43.5–65.7) 45.9 (36.0–56.4) NA
Specificity 95.1 (92.7–96.8) 97.9 (95.5–99.7) NA
PPV 66.7 (54.3–77.6) 87.3 (74.0–98.1) NA
NPV 92.1 (89.3–94.3) 84.9 (79.4–89.6) NA
Panbio Duo cassette IgM
Sensitivity 50.0 (38.9–61.1) 54.5 (45.4–63.8) 39.7 (35.2–44.1)
Specificity 89.5 (86.3–92.1) 95.5 (92.0–98.3) 96.6 (94.6–98.5)
PPV 46.2 (35.6–56.9) 79.5 (63.5–92.3) 79.2 (64.2–91.9)
NPV 90.8 (87.8–93.3) 86.8 (81.7–90.6) 83.3 (78.5–87.3)
Panbio Duo cassette IgG
Sensitivity 61.9 (50.7–72.3) 62.1 (52.8–71.4) 42.6 (38.1–47.1)
Specificity 79.6 (75.6–83.1) 84.5 (80.1–88.5) 87.2 (85.4–89.1)
PPV 35.4 (27.7–43.7) 56.2 (44.6–67.6) 51.7 (41.3–61.6)
NPV 92.0 (88.9–94.5) 87.5 (82.2–91.6) 82.6 (77.5–86.8)
Panbio NS1+IgMc
Sensitivity 79.8 (69.6–87.7) 78.9 (72.4–84.8) 72.8 (66.5–78.7)
Specificity 86.2 (82.8–89.2) 93.7 (90.7–96.8) 94.7 (91.9–97.5)
PPV 51.1 (42.3–60.0) 80.1 (68.2–90.6) 81.5 (69.8–91.6)
NPV 95.9 (93.6–97.6) 93.3 (89.5–95.9) 91.6 (87.5–94.5)
Panbio NS1+IgM+IgGc
Sensitivity 92.9 (85.1–97.3) 91.7 (86.2–96.1) 87.0 (81.2–92.0)
Specificity 72.5 (68.2–76.5) 79.8 (76.6–83.3) 82.8 (79.9–86.0)
PPV 37.9 (31.2–44.9) 59.3 (48.9–69.0) 62.0 (51.8–71.4)
NPV 98.3 (96.2–99.4) 96.8 (93.9–98.7) 95.2 (91.9–97.5)
aPrevalence and accuracy of each test was estimated by the observed proportion classified by considering that the reference assay was perfect (100% sensitivity and
100% specificity). 95% confidence intervals (CI) were obtained in Stata 11.1.
bPrevalence and accuracy of each test was estimated by Bayesian latent class models by considering that the reference assay could be imperfect. Posterior estimates
and 95% credible intervals (CrI) of each parameter were obtained in WinBUGs from 10,000 iterations of each of two chains starting from different initial values following
a burn-in period of 5,000 iterations.
cA combination considers that positivity of either test is positive for dengue infection.
NA=Not applicable.
doi:10.1371/journal.pone.0050765.t001
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Sensitivity analysis
Sensitivity analysis was performed in which 259 of 549 (47.2%)
patients without convalescent samples were excluded. By use of the
best-fitted Bayesian LCM, the sensitivities of our reference assay,
IgM cassette test and IgG cassette test were estimated to be 76.3%
(95% CrI 59.2%–90.4%), 60.8% (95% CrI 49.5%–71.7%) and
68.3% (95% CrI 57.0%–78.3%), respectively, for patients
suspected of dengue infection who had a convalescent sample.
Specificity of those tests was not substantially different from the
previous estimate, although all CrIs were wider as a consequence
of the reduced sample sizes. There was no substantial change
when different prior information was used (Table S1).
Discussion
The key findings of this study are that the true sensitivity of our
reference assay (AFRIMS MAC and GAC ELISA on paired
serum) estimated by Bayesian LCM was very low (62.0%). The
reduction in sensitivity of our reference assay from 100% assumed
by the gold standard model to 62% as estimated by the Bayesian
LCM model is due to the difference in the estimation methods.
While the gold standard model assumed that our reference assay is
perfect (sensitivity = 100%), Bayesian LCM estimated the true
sensitivity of our reference assay using the results of every
diagnostic test included in the model. Bayesian LCM also gave
an estimated prevalence of 24.3% in patients who were suspected
of dengue infection, compared with 15.3% based on our reference
assay alone. This higher estimated prevalence is credible, since
24.6% patients had final diagnosis of dengue fever or dengue
hemorrhagic fever based on the WHO definition and the
exclusion of other diseases.
There are several potential explanations as to why our reference
assay had such a low sensitivity in our setting. In common with
other research and reflecting real life, we also failed to obtain a
convalescent serum specimen from 47.2% of patients, either
because they died, they refused to be bled on discharge, or they
were lost to follow-up. The results from our sensitivity analysis
show that sensitivity of our reference assay was 76.3% (95% CrI
59.2%–90.4%) in the ideal situation, in which convalescent
samples were obtained from all patients. This increase in sensitivity
is consistent with existing knowledge; however, this also suggests
that a number of patients with dengue infection had a false-
negative test result by our reference assay even if a convalescent-
phase sample was available. Other possible explanations for the
low sensitivity of our reference assay are that patients with dengue
infection have variation in their immune response, insufficient
time between paired serum collections, and that the cutoff level of
DEN MAC and GAC ELISA used might not be optimal to detect
some patients with true dengue infection [11].
Evaluation of diagnostic tests when the accuracy of the gold
standard is unknown is an active area of biostatistical research, as
the use of an imperfect gold standard to evaluate the accuracy of
alternative tests is flawed and leads to biased results [18,24]. Our
study has shown that our reference assay represents a flawed
reference standard against which to compare alternative diagnostic
tests for dengue infection in a prospective study, and in this study
we have demonstrated the usefulness of statistical models under
such circumstances. For example, when compared with our
reference assay, the IgM cassette test had a specificity of 89.5%
(95% CI 86.3–92.1), representing a mediocre diagnostic test.
When recalculated using Bayesian LCMs, the specificity of the
IgM cassette test was 95.5% (95% CrI 92.0–98.3), representing a
test with a high degree of specificity. The range of 95% CrI for
specificity of the IgM cassette test estimated by the Bayesian LCM
barely overlaps the range of 95% CI estimated by the gold
standard model. When assessing the diagnostic utility of these
rapid tests, use of estimates derived using Bayesian LCMs is
preferable as they are unbiased by the false assumption that our
reference assay is perfect.
Considering the true prevalence of dengue infection in a cohort
population, Bayesian LCMs can be used to calculate unbiased
estimates of PPV and NPV to determine the clinical usefulness of
each diagnostic test and combinations of those tests. A combina-
tion of NS1, IgM and IgG on admission samples had an NPV of
95.2%, suggesting that negativity of all three tests could be used to
rule out dengue infection with a high degree of accuracy in our
setting. In addition, a combination of NS1 and IgM on the
admission sample had a PPV of 81.5%, suggesting that positivity
Table 2. Description and model selection criteria.
Model Correlationa Scientific Background DICb AICc
0 None It is possible that all (NS1, IgM, IgG and the reference assay) are not correlated. 113.9 110.3
1 IgM and the reference assay IgM and the reference assay are based on IgM response. Both tests are more likely
to be positive if the amount of IgM in blood in an infected subject is high, and to
be negative if the amount of IgM in blood in the infected subject is low.
113.0 111.1
2 IgM and IgG IgM and IgG are based on antibody response. Both tests are more likely to be positive
if antibody response in an infected subject is high, and to be negative if antibody
response in the infected subject is low.
108.5 106.7
3 IgG and the reference assay IgG and the reference assay are based on IgG response. Both tests are more likely to
be positive if the amount of IgG in blood in an infected subject is high, and to be
negative if the amount of IgG in blood in the infected subject is low.
112.6 110.9
4 IgM, IgG and the reference assay IgM, IgG and the reference assay are based on antibody response. All three tests
are more likely to be positive if antibody response in an infected subject is high,
and to be negative if antibody response in the infected subject is low.
NA 110.7
aAll correlations were in infected subjects.
bDIC (deviance information criteria) is a generalization of AIC in a Bayesian setting. DIC was not applicable (NA) in model 4, which assumed a correlation between more
than two tests.
cAIC (akaike information criteria) were used to evaluate goodness of model fit and to compare models.
A difference in DIC or AIC of more than 10 indicated definite support to the model with the lower value, while a difference of between 5 and 10 was considered
substantial, and less than 5 inconclusive.
doi:10.1371/journal.pone.0050765.t002
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of either NS1 or IgM could be used to diagnose dengue infection
with high level of confidence. This is consistent with many
previous studies describing potential combinations of two or three
tests in clinical setting [6,16,25–27]. It can be seen that the gold
standard model minimally overestimates NPV for the combination
of NS1, IgM and IgG performed on the admission samples
compared to the Bayesian LCM (97.8 [95% CI 95.7–99.0] vs. 95.2
[95% CrI 91.9–97.5]), and markedly underestimates PPV for the
combination of NS1 and IgM performed on the admission samples
compared to the Bayesian LCM (47.1 [95% CI 37.8–56.4] vs. 81.5
[95% CrI 69.8–91.6]). Again, estimates by Bayesian LCM should
be used because it does not falsely assume that our reference assay
is perfect. Note that median duration of symptoms between onset
of symptoms and collection of on-admission sample in our study
was 5 days.
The data set inconclusively supported a positive correlation
between the two serological tests detecting IgM and IgG immune
response in patients with dengue, a finding that could be
interpreted as meaning that both IgM and IgG cassette tests are
more likely to be positive if the immune response is high, and to be
negative if it is low. A positive correlation was not found between
the IgM cassette test and the reference assay and between the IgG
cassette test and the reference assay, even though our reference
assays detect the response of both antibodies to dengue infection.
Possible explanations are that the technology and antigens used for
the IgM and IgG cassette tests were different from those used for
the DEN MAC and GAC ELISA, respectively. This is supported
by the simple tabulation and Kappa statistics that demonstrated
poor agreement between the IgM cassette test and the reference
assay (Kappa value = 0.38) and between the IgG cassette test and
the reference assay (Kappa value = 0.32).
This study has several limitations. Using basic Bayesian LCMs
to estimate the sensitivity and specificity of each test in a
population does not allow us to determine the effect on these
parameters of symptom duration, antimicrobials received prior to
presentation, and timing of convalescent samples at the level of
individual patients. These effects could be evaluated in advanced
Bayesian LCMs [28]. Evaluation of other diagnostic tests,
including viral isolation and HAI, was not done as those tests
were not performed in our cohort study. PCR was performed in
only a subset of patients who had our reference assay positive to
determine serotype identity or who provided admission samples
only [29]; therefore, PCR could not be assessed using Bayesian
LCM in this study. It should be noted that the rapid diagnostic
tests evaluated in this study are earlier versions of rapid tests for
NS1, IgM and IgG. Currently available versions of these rapid
diagnostic tests were only evaluated in the case-control data set of
our cohort study; therefore, these newer tests could not be assessed
using Bayesian LCM.
We conclude that our reference assay, a combination of
AFRIMS DEN MAC and GAC ELISA on paired serum, has
lower than expected sensitivity as it does not take dengue virus
detection into consideration and hence is an imperfect gold
standard against which to compare alternative diagnostic tests.
Bayesian LCMs could be used to evaluate the accuracy of
alternative diagnostic tests when the accuracy of the gold standard
is unknown or is imperfect. On clinical presentation, a combina-
tion of the NS1, IgM and IgG cassette tests could be used as a set
of rapid diagnostic tests for diagnosing dengue infection with a
high level of accuracy.
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